Orion
Pharmaceutical company developing, manufacturing and marketing human and veterinary medicines and active ingredients for patients
Highlights
- New on EvolcAdded 2026-10-29
About Orion
Orion Pharma develops, manufactures and markets human and veterinary pharmaceuticals as well as active pharmaceutical ingredients. Its portfolio covers proprietary drugs developed in-house, generic medicines, self-care products, veterinary medicines and animal well-being products. Proprietary products are used to treat cancer, respiratory diseases and neurological diseases, among others.
Its products are sold in over a hundred countries. The company describes itself as a globally operating Nordic pharmaceutical company with a century-long history in healthcare; the registry records its founding as 2006. It operates six production sites in Finland and three R&D centres in Finland, the United Kingdom and the United States.
The company is headquartered in Espoo, Finland, and is listed on the stock exchange as Orion Oyj. Its website publishes stock exchange releases and quarterly reports, and it recruits for roles across research, quality, technical and IT functions.
Product: Human and veterinary pharmaceuticals, generic medicines, self-care products, animal well-being products and active pharmaceutical ingredients.
Public tenders won
11 tenders won since 1 Jan 2024 from 5 public buyers in Finland, worth €144.0M as awarded. From EU award notices (TED) that name Orion by its registry number.
- 5 Nov 2026 Pohjois-Pohjanmaan hyvinvointialue · Monoklonaaliset vasta-aineet ajalle 1.1.-31.12.2027 + optiovuosi 2028 Pohjois-Pohjanmaan hyvinvointialueelle · €24 notice
- 21 Sep 2026 Pirkanmaan hyvinvointialue · Rivaroksabaani- ja denosumabilääkevalmisteiden hankinta kaudelle 1.9.2026-31.12.2027 · €28k notice
- 8 Sep 2026 Pohjois-Pohjanmaan hyvinvointialue · Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027 · €142 notice
- 23 Apr 2025 Finnish Institute for Health and Welfare · Antibacterials, antimycobacterials and antimycotics for systemic use, part 2 · €1 notice
- 10 Mar 2025 Vankiterveydenhuollon yksikkö · Jälki-ilmoitus. Lääkevalmisteiden ja niihin rinnastettavien tuotteiden hankintaa koskeva tarjouspyyntö hankintakaudelle 2025-2026 · €6.0M notice
- 3 Feb 2025 Finnish Institute for Health and Welfare · Antibacterial and antimycobacterial products for systemic use · €1 notice
Jobs at Orion
More biotech & pharma companies
Oulu Mentalcare
Clinical drug trial site and private psychiatry practice in Oulu for depression and anxiety, plus supervision for managersNew on EvolcPCAS Finland
Contract manufacturer of active pharmaceutical ingredients and advanced intermediates for pharma companies, from Turku, FinlandNew on EvolcPharmamile
Marketing, sales and consulting for veterinary medicines and feed supplements, serving animal health industry players in FinlandYoung companyNew on EvolcPharmatest Services
Preclinical contract research in oncology and musculoskeletal disease models for pharma and biotech drug developersNew on EvolcPharmatory
Contract development and cGMP manufacturing of small-molecule APIs for human and veterinary pharma companiesNew on EvolcPolku Therapeutics
Develops small-molecule therapies for neurodegenerative diseases by targeting tau aggregation and neuroinflammationYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Tag Manager
- Tailwind CSS